161 related articles for article (PubMed ID: 34089839)
1. Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway.
Rastelli EJ; Sannino S; Hart DJ; Sharlow ER; Lazo JS; Brodsky JL; Wipf P
Bioorg Med Chem Lett; 2021 Aug; 46():128167. PubMed ID: 34089839
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase.
Lazo JS; Blanco IK; Tasker NR; Rastelli EJ; Burnett JC; Garrott SR; Hart DJ; McCloud RL; Hsu KL; Wipf P; Sharlow ER
J Pharmacol Exp Ther; 2019 Dec; 371(3):652-662. PubMed ID: 31601683
[TBL] [Abstract][Full Text] [Related]
3. Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer.
Lazo JS; Sharlow ER; Cornelison R; Hart DJ; Llaneza DC; Mendelson AJ; Rastelli EJ; Tasker NR; Landen CN; Wipf P
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209460
[TBL] [Abstract][Full Text] [Related]
4. Structure of the Complex of an Iminopyridinedione Protein Tyrosine Phosphatase 4A3 Phosphatase Inhibitor with Human Serum Albumin.
Czub MP; Boulton AM; Rastelli EJ; Tasker NR; Maskrey TS; Blanco IK; McQueeney KE; Bushweller JH; Minor W; Wipf P; Sharlow ER; Lazo JS
Mol Pharmacol; 2020 Dec; 98(6):648-657. PubMed ID: 32978326
[TBL] [Abstract][Full Text] [Related]
5. The dual inhibition against the activity and expression of tyrosine phosphatase PRL-3 from a rhodanine derivative.
Lin L; Lu L; Yuan C; Wang A; Zhu M; Fu X; Xing S
Bioorg Med Chem Lett; 2021 Jun; 41():127981. PubMed ID: 33766767
[TBL] [Abstract][Full Text] [Related]
6. Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells.
Min G; Lee SK; Kim HN; Han YM; Lee RH; Jeong DG; Han DC; Kwon BM
Bioorg Med Chem Lett; 2013 Jul; 23(13):3769-74. PubMed ID: 23726031
[TBL] [Abstract][Full Text] [Related]
7. In-flow photooxygenation of aminothienopyridinones generates iminopyridinedione PTP4A3 phosphatase inhibitors.
Tasker NR; Rastelli EJ; Blanco IK; Burnett JC; Sharlow ER; Lazo JS; Wipf P
Org Biomol Chem; 2019 Feb; 17(9):2448-2466. PubMed ID: 30746541
[TBL] [Abstract][Full Text] [Related]
8. Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents.
Sharlow ER; Wipf P; McQueeney KE; Bakan A; Lazo JS
Expert Opin Investig Drugs; 2014 May; 23(5):661-73. PubMed ID: 24625356
[TBL] [Abstract][Full Text] [Related]
9. A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.
McQueeney KE; Salamoun JM; Ahn JG; Pekic P; Blanco IK; Struckman HL; Sharlow ER; Wipf P; Lazo JS
FASEB J; 2018 Oct; 32(10):5661-5673. PubMed ID: 29746167
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J
Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jung MJ; Nam JM; Na Y; Cho WJ; Kwon Y; Lee ES
Bioorg Med Chem; 2010 Mar; 18(6):2245-2254. PubMed ID: 20188578
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-substituted Furo[3,2-b]pyridines Under Pd/C-Cu Catalysis Assisted by Ultrasound: Their Evaluation as Potential Cytotoxic Agents.
Laxmi DS; Vardhini SV; Guttikonda VR; Rao MVB; Pal M
Anticancer Agents Med Chem; 2020; 20(8):932-940. PubMed ID: 32160853
[TBL] [Abstract][Full Text] [Related]
13. Disruption of Ovarian Cancer STAT3 and p38 Signaling with a Small-Molecule Inhibitor of PTP4A3 Phosphatase.
Lazo JS; Isbell KN; Vasa SA; Llaneza DC; Rastelli EJ; Wipf P; Sharlow ER
J Pharmacol Exp Ther; 2023 Mar; 384(3):429-438. PubMed ID: 36627205
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Fluorescent Probes Targeting Tumor-Suppressor Protein FHIT and Identification of Apoptosis-Inducing FHIT Inhibitors.
Kawaguchi M; Sekimoto E; Ohta Y; Ieda N; Murakami T; Nakagawa H
J Med Chem; 2021 Jul; 64(13):9567-9576. PubMed ID: 34160227
[TBL] [Abstract][Full Text] [Related]
15. An epidermal growth factor receptor-targeted and endoplasmic reticulum-localized organic photosensitizer toward photodynamic anticancer therapy.
Zhao X; Ma H; Chen J; Zhang F; Jia X; Xue J
Eur J Med Chem; 2019 Nov; 182():111625. PubMed ID: 31442683
[TBL] [Abstract][Full Text] [Related]
16. Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries.
Tao Y; Hao X; Jing L; Sun L; Cherukupalli S; Liu S; Wu G; Xu S; Zhang X; Shi X; Song Y; Liu X; Zhan P
Bioorg Chem; 2021 Oct; 115():105254. PubMed ID: 34426152
[TBL] [Abstract][Full Text] [Related]
17. Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.
Tian M; Li J; Zhang S; Guo L; He X; Kong D; Zhang H; Liu Z
Chem Commun (Camb); 2017 Nov; 53(95):12810-12813. PubMed ID: 29143019
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase inhibition effects of novel Pyrazolo[1,5-a]pyrimidines and Pyrido[2,3-d]pyrimidines ligand: Synthesis, biological screening and molecular modeling studies.
El Sayed MT; Hussein HAR; Elebiary NM; Hassan GS; Elmessery SM; Elsheakh AR; Nayel M; Abdel-Aziz HA
Bioorg Chem; 2018 Aug; 78():312-323. PubMed ID: 29625271
[TBL] [Abstract][Full Text] [Related]
19. Photooxygenation of an amino-thienopyridone yields a more potent PTP4A3 inhibitor.
Salamoun JM; McQueeney KE; Patil K; Geib SJ; Sharlow ER; Lazo JS; Wipf P
Org Biomol Chem; 2016 Jul; 14(27):6398-402. PubMed ID: 27291491
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Preliminary Bioactivity Evaluation of 2,7-Substituted Carbazole Derivatives as Potent Autotaxin Inhibitors and Antitumor Agents†.
Wang W; Zhao F; Zhao Y; Pan W; Cao P; Wu L; Wang Z; Zhao X; Zhao Y; Wang H
Anticancer Agents Med Chem; 2019; 19(2):256-264. PubMed ID: 30173652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
